Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer

Condition:   Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Interventions:   Drug: Docetaxel;   Drug: Doxorubicin Hydrochloride;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Procedure: Therapeutic Conventional Surgery
Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
Not yet recruiting - verified July 2017

http://ift.tt/2uTDEnC